Stay updated on Naproxen-ASA Platelet Interaction Clinical Trial
Sign up to get notified when there's something new on the Naproxen-ASA Platelet Interaction Clinical Trial page.

Latest updates to the Naproxen-ASA Platelet Interaction Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor version update with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedLocations section now includes Texas as a location; the prior Texas Locations entry has been removed in the newer revision.SummaryDifference0.2%

- Check54 days agoChange DetectedPublications section wording updated to clarify that PubMed publications are automatically filled from PubMed and may not all pertain to the study. Page revision indicator updated to v3.3.2.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the site-wide funding/operating status notice; no study content, eligibility criteria, or outcome data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe screenshots show a minor UI refresh of the Study Details page with updated formatting and layout, but there are no changes to core content such as eligibility criteria, endpoints, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check104 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to Naproxen-ASA Platelet Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naproxen-ASA Platelet Interaction Clinical Trial page.